T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.86B |
| 2 |
VMW
VMware, Inc
VMW
|
+$1.49B |
| 3 |
Broadcom
AVGO
|
+$1.29B |
| 4 |
Sempra
SRE
|
+$1.26B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$1.66B |
| 2 |
HCA Healthcare
HCA
|
+$1.02B |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$949M |
| 4 |
American Tower
AMT
|
+$931M |
| 5 |
FRC
First Republic Bank
FRC
|
+$890M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.07% |
| 2 | Financials | 16.19% |
| 3 | Technology | 16.15% |
| 4 | Consumer Discretionary | 13.93% |
| 5 | Industrials | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Helmerich & Payne
HP
$4.29B
| $12.2M | ﹤0.01% |
188,204
| – | – |
|
1302
Standex International
SXI
$4B
| $12.1M | ﹤0.01% |
119,060
-3,545
| -3% | -$366K |
|
|
OXFD
1303
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $12M | ﹤0.01% |
858,201
+109,574
| +15% | +$1.61M |
|
1304
Fluor
FLR
$6.96B
| $11.9M | ﹤0.01% |
230,624
+3,700
| +2% | +$172K |
|
|
GOLD
1305
DELISTED
Randgold Resources Ltd
GOLD
| $11.8M | ﹤0.01% |
119,668
-3,188
| -3% | -$303K |
|
1306
Zai Lab
ZLAB
$2.86B
| $11.8M | ﹤0.01% |
556,100
+5,100
| +0.9% | +$136K |
|
1307
e.l.f. Beauty
ELF
$5.43B
| $11.8M | ﹤0.01% |
526,798
+3,600
| +0.7% | +$76.8K |
|
1308
Onto Innovation
ONTO
$20.6B
| $11.6M | ﹤0.01% |
467,122
+1,508
| +0.3% | +$40.2K |
|
1309
Abeona Therapeutics
ABEO
$425M
| $11.6M | ﹤0.01% |
29,370
+21,011
| +251% | +$8.69M |
|
1310
Oil States International
OIS
$536M
| $11.5M | ﹤0.01% |
404,691
-238
| -0.1% | -$5.77K |
|
|
SCG
1311
DELISTED
Scana
SCG
| $11.4M | ﹤0.01% |
287,804
-13,900
| -5% | -$621K |
|
|
PBNC
1312
DELISTED
PARAGON COMMERCIAL CORPORATION
PBNC
| $11.4M | ﹤0.01% |
214,961
-7,200
| -3% | -$411K |
|
1313
Comfort Systems
FIX
$60.8B
| $11.4M | ﹤0.01% |
261,966
-4,100
| -2% | -$168K |
|
|
ZAYO
1314
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $11.3M | ﹤0.01% |
308,013
+262,260
| +573% | +$9.27M |
|
|
HA
1315
DELISTED
Hawaiian Holdings, Inc.
HA
| $11.3M | ﹤0.01% |
282,430
+25,175
| +10% | +$968K |
|
|
TVTY
1316
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $11.2M | ﹤0.01% |
306,513
-5,390
| -2% | -$204K |
|
1317
Quanta Services
PWR
$101B
| $11.1M | ﹤0.01% |
283,780
-2,500
| -0.9% | -$93.8K |
|
|
FLIR
1318
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $11.1M | ﹤0.01% |
237,774
| – | – |
|
1319
iShares MSCI India ETF
INDA
$6.58B
| $11.1M | ﹤0.01% |
306,900
| – | – |
|
1320
Xerox
XRX
$412M
| $11M | ﹤0.01% |
379,010
+2,420
| +0.6% | +$73.5K |
|
1321
AnaptysBio
ANAB
$1.66B
| $11M | ﹤0.01% |
+109,097
| New | +$8.03M |
|
1322
Leggett & Platt
LEG
$1.29B
| $10.9M | ﹤0.01% |
228,066
+4,100
| +2% | +$194K |
|
|
NFX
1323
DELISTED
Newfield Exploration
NFX
| $10.8M | ﹤0.01% |
343,437
-27,240
| -7% | -$826K |
|
|
FBR
1324
DELISTED
Fibria Celulose Sa
FBR
| $10.8M | ﹤0.01% |
736,200
-64,800
| -8% | -$985K |
|
1325
Range Resources
RRC
$9.39B
| $10.8M | ﹤0.01% |
633,295
-92,200
| -13% | -$1.66M |
|
Similar funds
T. Rowe Price Associates's Q4 2017 Portfolio in Review
As of Q4 2017, T. Rowe Price Associates held 2,692 positions worth $616B, up 5.3% from $585B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
T. Rowe Price Associates's Q4 2017 filing shows 121 new, 947 increased, 1,282 reduced and 130 closed positions. Its largest new stake was CarGurus: 13,060,603 shares worth $374M. The largest sale was PayPal, an estimated $1.66B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Financials and Technology.
- T. Rowe Price Associates's largest Q4 2017 buy was CarGurus: 13,060,603 shares worth $374M.
- T. Rowe Price Associates added most to Tesla in Q4 2017, an estimated $1.86B increase.
- T. Rowe Price Associates's biggest Q4 2017 reduction was PayPal, cutting an estimated $1.66B.
- T. Rowe Price Associates fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $483M.
- T. Rowe Price Associates's ten largest holdings make up 19% of its $616B portfolio in Q4 2017.
- T. Rowe Price Associates opened 121 new positions and closed 130 in Q4 2017.
- T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $616B.
Based on T. Rowe Price Associates's 13F filing for Q4 2017, filed 14 Feb 2018.